HealthTree
[logo] HealthTree Foundation
search more_vert
close
person Sign In / Create Account
Search By NCT Number
Search By Keyword
Genetics & Targets
Phases
Primary Purpose
Country
State
Showing 1 trials matching your filters.
Study to Evaluate the Efficacy and Safety of Sonrotoclax in Participants With Waldenström's Macroglo...
This study will evaluate the safety and efficacy of the BCL2 inhibitor BGB-11417 (sonrotoclax) in participants with relapsed/refractory Waldenström's Macroglobulinemia (R/R WM) and in combination with zanubrutinib in adult participants with previousl...

DRUG: BGB-11417

DRUG: Zanubrutinib

All the HealthTree resources anywhere, anytime.
Download our App
Download iOS App Download Android App
iphone app mockup
newsletter icon

Stay Informed. Get the Support You Need for Waldenström's Macroglobulinemia.

By subscribing to the Healthtree newsletter, you'll receive the latest research, treatment updates, and expert insights to help you navigate your health.

Education

News Articles My Journal University Expert Webinars Find a Specialist HealthTree Podcast

Community

Connect Moves All Events

Cure Hub

HealthTree Cure Hub Find Side Effects Solutions See Tracked Labs Connect Medical Records Twin Machine Clinical Trial Finder

Get Involved

Join a Regional Cure Team Create a fundraiser Tribute Donate Patient Surveys & Studies Connect Medical Records

About us

Our Story

Need Help?

Contact Us FAQ & Help Center 1-800-709-1113

Legal Info

Terms of Use Privacy Policy
Download our App
Download iOS App Download Android App

Charity Navigator https://www.guidestar.org/profile/45-5354811

HealthTree Foundation is a qualified 501(c)(3) tax-exempt organization.

Copyright © 2025 HealthTree Foundation. All rights reserved.

Tax ID 45-5354811